Detalles de la búsqueda
1.
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression in patients with acute lymphoblastic leukemia - update of single center study.
Neoplasma
; 64(5): 762-769, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28592129
2.
Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experienc.
Neoplasma
; 62(1): 146-51, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25563379
3.
Allogeneic stem cell transplantation after fludarabine, melphalan and thymoglobulin followed by early withdrawal of prophylactic immunosuppression could be an effective approach to patients with acute lymphoblastic leukemia.
Neoplasma
; 62(5): 805-11, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26278139
4.
Secondary acute myeloid leukemia - a single center experience.
Neoplasma
; 57(2): 170-8, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20099982
5.
Flow cytometric monitoring of the in vitro inhibition of the phosphorylation of CRKL and of SRC family kinases in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
Int J Lab Hematol
; 37(1): e11-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24845482
6.
Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph(+)CD34(+)CD38(neg)) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy.
Leukemia
; 24(1): 219-22, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19776759
Resultados
1 -
6
de 6
1
Próxima >
>>